Health Encyclopedia

 

 

Multiple Endocrine Neoplasia Type 2

National Organization for Rare Disorders, Inc.

Important

It is possible that the main title of the report Multiple Endocrine Neoplasia Type 2 is not the name you expected. Please check the synonyms listing to find the alternate name(s) and disorder subdivision(s) covered by this report.

Synonyms

  • MEN-2
  • MEN-2 syndrome

Disorder Subdivisions

  • familial medullary thyroid carcinoma (FMTC)
  • MEN 2A (Sipple syndrome)
  • MEN 2B (multiple neuroma syndrome)
  • multiple endocrine neoplasia type 2A
  • multiple endocrine neoplasia type 2B
  • Wagenmann-Froboese syndrome

General Discussion

Multiple endocrine neoplasia (MEN) type 2 is a rare genetic disorder characterized by an increased risk of developing a specific form of thyroid cancer (medullary thyroid carcinoma) and benign tumors affecting additional glands of the endocrine system. The endocrine system is the network of glands that secrete hormones into the bloodstream where they travel to various areas of the body. These hormones regulate the chemical processes (metabolism) that influence the function of various organs and activities within the body. Hormones are involved in numerous vital processes including regulating heart rate, body temperature and blood pressure. Glands affected in MEN type 2 may secrete excessive amounts of hormones into the bloodstream, which can result in a variety of symptoms.



MEN type 2 is divided into three subtypes: MEN type 2A, MEN type 2B, and familial medullary thyroid carcinoma (FMTC). Medullary thyroid carcinoma (MTC) affects nearly all individuals with MEN type 2 regardless of the subtype. Additional symptoms may occur depending upon the specific subtype present. In FMTC, no other symptoms besides the carcinoma are present. MEN type 2 can run in families or can occur as the result of a spontaneous genetic change (i.e., new mutation) that occurs randomly for no apparent reason.

Resources

American Cancer Society, Inc.

250 Williams NW St

Ste 6000

Atlanta, GA 30303

USA

Tel: (404)320-3333

Tel: (800)227-2345

TDD: (866)228-4327

Internet: http://www.cancer.org



NIH/National Institute of Diabetes, Digestive & Kidney Diseases

Office of Communications & Public Liaison

Bldg 31, Rm 9A06

31 Center Drive, MSC 2560

Bethesda, MD 20892-2560

Tel: (301)496-3583

Email: NDDIC@info.niddk.nih.gov

Internet: http://www2.niddk.nih.gov/



Canadian Multiple Endocrine Neoplasia Society, Inc.

1432 107th Street

North Battleford, S9A 19

Canada

Tel: 3064458436

Fax: 3064458436

Email: hockey_freak99@hotmail.com



Hormone Health Network

8401 Connecticut Avenue

Suite 900

Chevy Chase, MD 20815-5817

Fax: (310)941-0259

Tel: (800)467-6663

Email: hormone@endo-society.org

Internet: http://www.hormone.org/



ThyCa: Thyroid Cancer Survivors' Association, Inc.

PO Box 1545

New York, NY 10159-1545

Fax: (630)604-6078

Tel: (877)588-7904

Email: thyca@thyca.org

Internet: http://www.thyca.org



Association for Multiple Endocrine Neoplasia Disorders (AMEND)

The Warehouse

No. 1 Draper Street

Royal Tunbridge Wells

Kent, TN4 0PG

United Kingdom

Tel: 00441892516076

Fax: 00441892516076

Email: jo.grey@amend.org.uk

Internet: http://www.amend.org.uk



NET Patient Foundation

Boxtrees Farm

The Farm House

Stratford Road

Hockley Heath, B94 6EA

United Kingdom

Tel: 08004346476

Internet: http://www.netpatientfoundation.org



American Multiple Endocrine Neoplasia Support

1027 Hampshire Drive

Maryville, TN 37801

Tel: (865)238-5872

Fax: (865)238-5844

Tel: (866)612-8579

Email: Linda@hagemanfoundation.org

Internet: http://www.amensupport.org



Pheo Para Troopers

P.O. Box 2064

Kokomo, IN 46904

Email: info@pheoparatroopers.org

Internet: http://www.pheoparatroopers.org



Hageman Foundation

1027 Hampshire Drive

Maryville, TN 37801

Tel: (865)238-5842

Fax: (865)238-5844

Tel: (866)612-8579

Email: Info@HagemanFoundation.org

Internet: http://www.HagemanFoundation.org



For a Complete Report

This is an abstract of a report from the National Organization for Rare Disorders (NORD). A copy of the complete report can be downloaded free from the NORD website for registered users. The complete report contains additional information including symptoms, causes, affected population, related disorders, standard and investigational therapies (if available), and references from medical literature. For a full-text version of this topic, go to MyD-H, the Dartmouth-Hitchcock patient portal. You must be a registered MyD-H user for the Lebanon, Manchester, or Nashua locations to access this site.

The information provided in this report is not intended for diagnostic purposes. It is provided for informational purposes only. NORD recommends that affected individuals seek the advice or counsel of their own personal physicians.

It is possible that the title of this topic is not the name you selected. Please check the Synonyms listing to find the alternate name(s) and Disorder Subdivision(s) covered by this report

This disease entry is based upon medical information available through the date at the end of the topic. Since NORD's resources are limited, it is not possible to keep every entry in the Rare Disease Database completely current and accurate. Please check with the agencies listed in the Resources section for the most current information about this disorder.

For additional information and assistance about rare disorders, please contact the National Organization for Rare Disorders at P.O. Box 1968, Danbury, CT 06813-1968; phone (203) 744-0100; web site www.rarediseases.org or email orphan@rarediseases.org

Last Updated:  1/20/2011

Copyright  2011 National Organization for Rare Disorders, Inc.

This information does not replace the advice of a doctor. Healthwise, Incorporated disclaims any warranty or liability for your use of this information. Your use of this information means that you agree to the Terms of Use. How this information was developed to help you make better health decisions.

Healthwise, Healthwise for every health decision, and the Healthwise logo are trademarks of Healthwise, Incorporated.